BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Z, Chen X, Li J, Guo Y, Li H, Pan X, Jiang J, Liu H, Wu B. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer. Oncotarget. 2016;7:25408-25419. [PMID: 27028998 DOI: 10.18632/oncotarget.8323] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Kriz D, Ansari D, Andersson R. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2020;22:2170-2174. [PMID: 32447642 DOI: 10.1007/s12094-020-02372-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mortoglou M, Tabin ZK, Arisan ED, Kocher HM, Uysal-Onganer P. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Transl Oncol 2021;14:101090. [PMID: 33831655 DOI: 10.1016/j.tranon.2021.101090] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu J, Li Y, Zhang Q, Lv C, Wang M, Jiao Y, Wang C. PVT1 Expression Is a Predictor for Poor Survival of Prostate Cancer Patients. Technol Cancer Res Treat 2021;20:1533033820971610. [PMID: 33752525 DOI: 10.1177/1533033820971610] [Reference Citation Analysis]
4 Hassanzarei S, Hashemi M, Sattarifard H, Hashemi SM, Bahari G, Ghavami S. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population. Tumour Biol 2017;39:101042831772753. [DOI: 10.1177/1010428317727539] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
5 Ma Z, Huang H, Wang J, Zhou Y, Pu F, Zhao Q, Peng P, Hui B, Ji H, Wang K. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget 2017;8:84153-67. [PMID: 29137412 DOI: 10.18632/oncotarget.20359] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
6 Hu P, Qiao O, Wang J, Li J, Jin H, Li Z, Jin Y. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Oncol. 2017;15:155. [PMID: 28818070 DOI: 10.1186/s12957-017-1218-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
7 Ou ZL, Luo Z, Lu YB. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World J Gastroenterol 2019; 25(46): 6728-6742 [PMID: 31857775 DOI: 10.3748/wjg.v25.i46.6728] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
8 Rapado-González Ó, Martínez-Reglero C, Salgado-Barreira Á, Takkouche B, López-López R, Suárez-Cunqueiro MM, Muinelo-Romay L. Salivary biomarkers for cancer diagnosis: a meta-analysis. Ann Med 2020;52:131-44. [PMID: 32056455 DOI: 10.1080/07853890.2020.1730431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
9 Zou H, Wu LX, Yang Y, Li S, Mei Y, Liu YB, Zhang L, Cheng Y, Zhou HH. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients. Oncotarget 2017;8:78767-80. [PMID: 29108264 DOI: 10.18632/oncotarget.20226] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
10 Wu B, Wang K, Fei J, Bao Y, Wang X, Song Z, Chen F, Gao J, Zhong Z. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer. Oncol Rep 2018;40:3427-37. [PMID: 30542694 DOI: 10.3892/or.2018.6761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
11 Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies. Cancers (Basel) 2019;11:E1170. [PMID: 31416190 DOI: 10.3390/cancers11081170] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 19.3] [Reference Citation Analysis]
12 Shademan M, Naseri Salanghuch A, Zare K, Zahedi M, Foroughi MA, Akhavan Rezayat K, Mosannen Mozaffari H, Ghaffarzadegan K, Goshayeshi L, Dehghani H. Expression profile analysis of two antisense lncRNAs to improve prognosis prediction of colorectal adenocarcinoma. Cancer Cell Int 2019;19:278. [PMID: 31708689 DOI: 10.1186/s12935-019-1000-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
13 Lei L, Wang J, Zhang L, Chen Y, Yuan P, Liu D. Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancer. Oncotarget 2017;8:89149-59. [PMID: 29179507 DOI: 10.18632/oncotarget.20803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Onagoruwa OT, Pal G, Ochu C, Ogunwobi OO. Oncogenic Role of PVT1 and Therapeutic Implications. Front Oncol 2020;10:17. [PMID: 32117705 DOI: 10.3389/fonc.2020.00017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
15 Sturque J, Berquet A, Loison-robert L, Ahossi V, Zwetyenga N. Interest of studying the saliva metabolome, transcriptome and microbiome in screening for pancreatic cancer. Journal of Stomatology, Oral and Maxillofacial Surgery 2019;120:554-8. [DOI: 10.1016/j.jormas.2019.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lin QY, Qi QL, Hou S, Chen Z, Zhang L, Zhao HG, Lin CH. LncRNA PVT1 Acts as a Tumor Promoter in Thyroid Cancer and Promotes Tumor Progression by Mediating miR-423-5p-PAK3. Cancer Manag Res 2020;12:13403-13. [PMID: 33408513 DOI: 10.2147/CMAR.S283443] [Reference Citation Analysis]
17 Zhou DD, Liu XF, Lu CW, Pant OP, Liu XD. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer. Cell Prolif. 2017;50. [PMID: 29027279 DOI: 10.1111/cpr.12398] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
18 Fu CJ, Cong J, Sun SS, Ren MM, Xie SY, Wang PY. Diagnostic roles of HOX transcript antisense intergenic RNA in cancer. Asia Pac J Clin Oncol 2021;17:e3-9. [PMID: 32030884 DOI: 10.1111/ajco.13300] [Reference Citation Analysis]
19 Cai H, An Y, Chen X, Sun D, Chen T, Peng Y, Zhu F, Jiang Y, He X. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2. Oncotarget 2016;7:86857-70. [PMID: 27895308 DOI: 10.18632/oncotarget.13490] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
20 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chen Y, Guo Y, Chen H, Ma F. Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma. Front Neurol 2020;11:573264. [PMID: 33329315 DOI: 10.3389/fneur.2020.573264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Ghafouri-Fard S, Dashti S, Farsi M, Taheri M. HOX transcript antisense RNA: An oncogenic lncRNA in diverse malignancies. Exp Mol Pathol 2021;118:104578. [PMID: 33238156 DOI: 10.1016/j.yexmp.2020.104578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhou G, Zeng Y, Luo Y, Guo S, Bao L, Zhang Q. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma. Eur J Surg Oncol 2021:S0748-7983(21)00579-5. [PMID: 34175168 DOI: 10.1016/j.ejso.2021.06.015] [Reference Citation Analysis]
24 Jiang Y, Wang T, Yan L, Qu L. A novel prognostic biomarker for pancreatic ductal adenocarcinoma: hsa_circ_0001649. Gene. 2018;675:88-93. [PMID: 29969694 DOI: 10.1016/j.gene.2018.06.099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
25 Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS. Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. Onco Targets Ther 2018;11:2333-44. [PMID: 29731641 DOI: 10.2147/OTT.S157551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
26 Dehghanian F, Azhir Z, Khalilian S, Grüning B. Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. J Diabetes Investig 2021. [PMID: 34859606 DOI: 10.1111/jdi.13727] [Reference Citation Analysis]
27 Zhou B, Xu JW, Cheng YG, Gao JY, Hu SY, Wang L, Zhan HX. Early detection of pancreatic cancer: Where are we now and where are we going? Int J Cancer. 2017;141:231-241. [PMID: 28240774 DOI: 10.1002/ijc.30670] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 15.8] [Reference Citation Analysis]
28 Wu T, Du Y. LncRNAs: From Basic Research to Medical Application. Int J Biol Sci 2017;13:295-307. [PMID: 28367094 DOI: 10.7150/ijbs.16968] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
29 Price RL, Bhan A, Mandal SS. HOTAIR beyond repression: In protein degradation, inflammation, DNA damage response, and cell signaling. DNA Repair (Amst) 2021;105:103141. [PMID: 34183273 DOI: 10.1016/j.dnarep.2021.103141] [Reference Citation Analysis]
30 Gutschner T, Richtig G, Haemmerle M, Pichler M. From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer. Cancer Metastasis Rev 2018;37:83-105. [PMID: 29247341 DOI: 10.1007/s10555-017-9718-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
31 Li Y, Li S, Luo Y, Liu Y, Yu N. LncRNA PVT1 Regulates Chondrocyte Apoptosis in Osteoarthritis by Acting as a Sponge for miR-488-3p. DNA Cell Biol 2017;36:571-80. [PMID: 28520497 DOI: 10.1089/dna.2017.3678] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 13.6] [Reference Citation Analysis]
32 Sun C, Wang P, Dong W, Liu H, Sun J, Zhao L. LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer. Aging (Albany NY) 2020;12:10427-40. [PMID: 32499447 DOI: 10.18632/aging.103268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
33 Balcin O, Ak Aksoy S, Tunca B, Kaya E, Egeli U, Tezcan G, Ugras N, Cecener G, Isik O, Dundar HZ, Yerci O. Overexpression of the Long Noncoding RNA HomeoboxA Transcript at the Distal Tip Predicts Poor Prognosis in a KRAS-Independent Manner in Periampullary Region Tumors. Pancreas 2018;47:213-20. [DOI: 10.1097/mpa.0000000000000984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Igelmann S, Neubauer HA, Ferbeyre G. STAT3 and STAT5 Activation in Solid Cancers. Cancers (Basel) 2019;11:E1428. [PMID: 31557897 DOI: 10.3390/cancers11101428] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
35 Sharma GG, Okada Y, Von Hoff D, Goel A. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol 2020:S1044-579X(20)30204-2. [PMID: 33049362 DOI: 10.1016/j.semcancer.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Makler A, Narayanan R. Mining Exosomal Genes for Pancreatic Cancer Targets. Cancer Genomics Proteomics 2017;14:161-72. [PMID: 28446531 DOI: 10.21873/cgp.20028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Gong R, Jiang Y. Non-coding RNAs in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020;10:309. [PMID: 32257946 DOI: 10.3389/fonc.2020.00309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
38 Kong W, Yang M, Zhu Y, Zuo X, Wang H, Chen W. Diagnostic value of HOX transcript antisense RNA for cancer detection: a meta-analysis. Biomark Med 2020;14:401-11. [PMID: 32270696 DOI: 10.2217/bmm-2019-0207] [Reference Citation Analysis]
39 Barwal TS, Sharma U, Rana MK, Bazala S, Singh I, Murmu M, Kapoor HS, Thakur S, Jain M, Jain A. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in Thyroid, Pancreatic and Ovarian Cancer. Crit Rev Oncol Hematol 2022;:103598. [PMID: 35033662 DOI: 10.1016/j.critrevonc.2022.103598] [Reference Citation Analysis]
40 Satoh K. Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer.Diagnostics (Basel). 2021;11. [PMID: 33671729 DOI: 10.3390/diagnostics11020375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Robless EE, Howard JA, Casari I, Falasca M. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer. Cancer Lett 2021;501:55-65. [PMID: 33359452 DOI: 10.1016/j.canlet.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jia W, Zhang J, Ma F, Hao S, Li X, Guo R, Gao Q, Sun Y, Jia J, Li W. Long noncoding RNA THAP9-AS1 is induced by Helicobacter pylori and promotes cell growth and migration of gastric cancer. Onco Targets Ther 2019;12:6653-63. [PMID: 32021238 DOI: 10.2147/OTT.S201832] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
43 Xiong G, Feng M, Yang G, Zheng S, Song X, Cao Z, You L, Zheng L, Hu Y, Zhang T, Zhao Y. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer. Cancer Lett. 2017;397:94-102. [PMID: 28254409 DOI: 10.1016/j.canlet.2017.02.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
44 Ghafouri-Fard S, Omrani MD, Taheri M. Long noncoding RNA PVT1: A highly dysregulated gene in malignancy. J Cell Physiol 2020;235:818-35. [PMID: 31297833 DOI: 10.1002/jcp.29060] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
45 Dragomir MP, Kopetz S, Ajani JA, Calin GA. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut 2020;69:748-63. [PMID: 32034004 DOI: 10.1136/gutjnl-2019-318279] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 23.0] [Reference Citation Analysis]
46 Heredia-Soto V, Rodríguez-Salas N, Feliu J. Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice? Cancers (Basel) 2021;13:1986. [PMID: 33924143 DOI: 10.3390/cancers13081986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M, Xiao L, Chen W. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study. Int J Mol Sci 2016;17:E1367. [PMID: 27556453 DOI: 10.3390/ijms17081367] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
48 Wang BQ, Wang JL, Zhang BQ, Li TT, Wang C, Sun GB. Role of long non-coding RNAs in development and progression of pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2022; 30(6): 274-279 [DOI: 10.11569/wcjd.v30.i6.274] [Reference Citation Analysis]
49 Sun J, Zhang P, Yin T, Zhang F, Wang W. Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A. J Cancer 2020;11:2572-9. [PMID: 32201527 DOI: 10.7150/jca.37959] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
50 Kołat D, Hammouz R, Bednarek AK, Płuciennik E. Exosomes as carriers transporting long non‑coding RNAs: Molecular characteristics and their function in cancer (Review). Mol Med Rep 2019;20:851-62. [PMID: 31173220 DOI: 10.3892/mmr.2019.10340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
51 Ghafouri-Fard S, Fathi M, Zhai T, Taheri M, Dong P. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules 2021;11:1665. [PMID: 34827663 DOI: 10.3390/biom11111665] [Reference Citation Analysis]
52 Shuai P, Zhou Y, Gong B, Jiang Z, Yang C, Yang H, Zhang D, Zhu S. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis. Springerplus 2016;5:1721. [PMID: 27777857 DOI: 10.1186/s40064-016-3342-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
53 Kunovsky L, Tesarikova P, Kala Z, Kroupa R, Kysela P, Dolina J, Trna J. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Can J Gastroenterol Hepatol 2018;2018:5389820. [PMID: 30186820 DOI: 10.1155/2018/5389820] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
54 Ma J, Fan Y, Feng T, Chen F, Xu Z, Li S, Lin Q, He X, Shi W, Liu Y, Liu Z, Zhu B, Cao X. HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. Oncotarget. 2017;8:86410-86422. [PMID: 29156804 DOI: 10.18632/oncotarget.21195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
55 Jiang D, Xu L, Ni J, Zhang J, Cai M, Shen L. Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer. Cancer Cell Int. 2019;19:47. [PMID: 30867650 DOI: 10.1186/s12935-019-0761-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
56 Wang J, Zhao L, Shang K, Liu F, Che J, Li H, Cao B. Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer. Mol Med 2020;26:30. [PMID: 32272875 DOI: 10.1186/s10020-020-00156-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Huang X, Zhi X, Gao Y, Ta N, Jiang H, Zheng J. LncRNAs in pancreatic cancer. Oncotarget. 2016;7:57379-57390. [PMID: 27429196 DOI: 10.18632/oncotarget.10545] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 11.3] [Reference Citation Analysis]
58 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457. [PMID: 32973402 DOI: 10.1186/s12935-020-01550-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Wu BQ, Jiang Y, Zhu F, Sun DL, He XZ. Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating p21 in Pancreatic Cancer Cells. Technol Cancer Res Treat 2017;16:819-27. [PMID: 28355965 DOI: 10.1177/1533034617700559] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
60 Xie Z, Zhou F, Yang Y, Li L, Lei Y, Lin X, Li H, Pan X, Chen J, Wang G, Liu H, Jiang J, Wu B. Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. EBioMedicine 2018;33:57-67. [PMID: 30045829 DOI: 10.1016/j.ebiom.2018.06.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
61 Xue W, Chen J, Liu X, Gong W, Zheng J, Guo X, Liu Y, Liu L, Ma J, Wang P, Li Z, Xue Y. PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p. Biochim Biophys Acta Mol Basis Dis 2018;1864:1783-94. [PMID: 29501773 DOI: 10.1016/j.bbadis.2018.02.022] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
62 Huo X, Han S, Wu G, Latchoumanin O, Zhou G, Hebbard L, George J, Qiao L. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16:165. [PMID: 29061150 DOI: 10.1186/s12943-017-0734-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 19.0] [Reference Citation Analysis]
63 Rajagopal T, Talluri S, Akshaya R, Dunna NR. HOTAIR LncRNA: A novel oncogenic propellant in human cancer. Clinica Chimica Acta 2020;503:1-18. [DOI: 10.1016/j.cca.2019.12.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
64 He Y, Jing Y, Wei F, Tang Y, Yang L, Luo J, Yang P, Ni Q, Pang J, Liao Q, Xiong F, Guo C, Xiang B, Li X, Zhou M, Li Y, Xiong W, Zeng Z, Li G. Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma. Cell Death Dis 2018;9:235. [PMID: 29445147 DOI: 10.1038/s41419-018-0265-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 86] [Article Influence: 16.8] [Reference Citation Analysis]
65 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Yao Y, Gao P, Chen L, Wang W, Zhang J, Li Q, Xu Y. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis. Gene 2018;659:52-8. [PMID: 29551494 DOI: 10.1016/j.gene.2018.03.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
67 Silverman BR, Shi J. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications. Int J Mol Sci 2016;17:E2138. [PMID: 27999365 DOI: 10.3390/ijms17122138] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
68 Martinez-Useros J, Martin-Galan M, Florez-Cespedes M, Garcia-Foncillas J. Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments. Cancers (Basel) 2021;13:3209. [PMID: 34198989 DOI: 10.3390/cancers13133209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Lv QL, Chen SH, Zhang X, Sun B, Hu L, Qu Q, Huang YT, Wang GH, Liu YL, Zhang YY, Zhou HH. Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma. Tumour Biol 2017;39:1010428317695022. [PMID: 28349823 DOI: 10.1177/1010428317695022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
70 Ramya Devi KT, Karthik D, Mahendran T, Jaganathan MK, Hemdev SP. Long noncoding RNAs: role and contribution in pancreatic cancer. Transcription 2021;12:12-27. [PMID: 34036896 DOI: 10.1080/21541264.2021.1922071] [Reference Citation Analysis]
71 Buzalaf MAR, Ortiz AC, Carvalho TS, Fideles SOM, Araújo TT, Moraes SM, Buzalaf NR, Reis FN. Saliva as a diagnostic tool for dental caries, periodontal disease and cancer: is there a need for more biomarkers? Expert Rev Mol Diagn 2020;20:543-55. [PMID: 32223655 DOI: 10.1080/14737159.2020.1743686] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
72 Zhu S, Shuai P, Yang C, Zhang Y, Zhong S, Liu X, Chen K, Ran Q, Yang H, Zhou Y. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis. Oncotarget 2017;8:113174-84. [PMID: 29348896 DOI: 10.18632/oncotarget.22830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
73 Zhou W, Chen L, Li C, Huang R, Guo M, Ning S, Ji J, Guo X, Lou G, Jia X, Zhao J, Luo F, Li C, Qu Z, Yu S, Tai S. The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know. Cancer Cell Int 2020;20:41. [PMID: 32042268 DOI: 10.1186/s12935-020-1126-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
74 Yong S, Yabin Y, Bing Z, Chuanrong Z, Dianhua G, Jianhuai Z, Weidong Y, Shuming W, Ling L. Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma. Oncotarget 2017;8:90868-78. [PMID: 29207609 DOI: 10.18632/oncotarget.18377] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
75 Mabeta P, Hull R, Dlamini Z. LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities. Genes 2022;13:152. [DOI: 10.3390/genes13010152] [Reference Citation Analysis]
76 Nie HX, Zhang L, He T, Wang L, Wan BS, Wang XQ, Han F. lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Front Oncol 2020;10:620550. [PMID: 33708618 DOI: 10.3389/fonc.2020.620550] [Reference Citation Analysis]
77 Martinez-Useros J, Garcia-Foncillas J. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? Biomed Res Int 2016;2016:4873089. [PMID: 27689078 DOI: 10.1155/2016/4873089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
78 Krappinger JC, Bonstingl L, Pansy K, Sallinger K, Wreglesworth NI, Grinninger L, Deutsch A, El-Heliebi A, Kroneis T, Mcfarlane RJ, Sensen CW, Feichtinger J. Non-coding Natural Antisense Transcripts: Analysis and Application. J Biotechnol 2021:S0168-1656(21)00210-8. [PMID: 34371054 DOI: 10.1016/j.jbiotec.2021.08.005] [Reference Citation Analysis]
79 Zeng Y, Wang T, Liu Y, Su Z, Lu P, Chen X, Hu D. LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis. Oncotarget 2017;8:75455-66. [PMID: 29088881 DOI: 10.18632/oncotarget.20634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
80 Meleti M, Cassi D, Vescovi P, Setti G, Pertinhez TA, Pezzi ME. Salivary biomarkers for diagnosis of systemic diseases and malignant tumors. A systematic review. Med Oral Patol Oral Cir Bucal 2020;25:e299-310. [PMID: 32040469 DOI: 10.4317/medoral.23355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
81 Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, Li Y, Wang ZW. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol 2020:S1044-579X(20)30222-4. [PMID: 33207266 DOI: 10.1016/j.semcancer.2020.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
82 Caputo D, Papi M, Coppola R, Palchetti S, Digiacomo L, Caracciolo G, Pozzi D. A protein corona-enabled blood test for early cancer detection. Nanoscale 2017;9:349-54. [DOI: 10.1039/c6nr05609a] [Cited by in Crossref: 56] [Cited by in F6Publishing: 15] [Article Influence: 11.2] [Reference Citation Analysis]
83 Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. [DOI: 10.1038/s41416-021-01672-8] [Reference Citation Analysis]
84 Samandari M, Julia MG, Rice A, Chronopoulos A, del Rio Hernandez AE. Liquid biopsies for management of pancreatic cancer. Translational Research 2018;201:98-127. [DOI: 10.1016/j.trsl.2018.07.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
85 Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim J, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant N, Magliocco A, Malafa MP, Gillies R. Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Sci Rep 2017;7:10484. [PMID: 28874676 DOI: 10.1038/s41598-017-09754-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
86 Cui Q, Feng FT, Xu M, Liu WS, Yao YY, Xie SH, Li XZ, Ye ZL, Feng QS, Chen LZ, Bei JX, Feng L, Huang QH, Jia WH, Cao SM, Chang ET, Ye W, Adami HO, Zeng YX. Nasopharyngeal carcinoma risk prediction via salivary detection of host and Epstein-Barr virus genetic variants. Oncotarget 2017;8:95066-74. [PMID: 29221111 DOI: 10.18632/oncotarget.11144] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
87 Jiang Y, Feng E, Sun L, Jin W, You Y, Yao Y, Xu Y. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma. Biomed Pharmacother 2017;95:685-91. [PMID: 28886528 DOI: 10.1016/j.biopha.2017.08.124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]